This Verisk Analytics Analyst Turns Bearish; Here Are Top 5 Downgrades For Thursday

+0.20%

-1.45%

-0.31%

-0.38%

+2.40%

Atmos Energy Corporation ATO	171.29	+0.20%
Astria Therapeutics Inc Ordinary Shares ATXS	12.93	-1.45%
First Horizon National Corporation FHN	22.76	-0.31%
Verisk Analytics Inc VRSK	221.24	-0.38%
Xometry, Inc. XMTR	59.79	+2.40%

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

HC Wainwright & Co. analyst Joseph Pantginis downgraded the rating for Astria Therapeutics Inc (NASDAQ:ATXS) from Buy to Neutral. Astria Therapeutics shares closed at $11.92 on Wednesday. See how other analysts view this stock.
B of A Securities analyst Julien Dumoulin-Smith downgraded Atmos Energy Corp (NYSE:ATO) from Buy to Neutral and raised the price target from $182 to $185. Atmos Energy shares closed at $179.19 on Wednesday. See how other analysts view this stock.
Evercore ISI Group analyst John Pancari downgraded First Horizon Corp (NYSE:FHN) from Outperform to In-Line and lowered the price target from $26 to $20. First Horizon shares closed at $20.85 on Wednesday. See how other analysts view this stock.
Rothschild & Co analyst Russell Quelch downgraded Verisk Analytics, Inc. (NASDAQ:VRSK) from Neutral to Sell and cut the price target from $280 to $220. Verisk Analytics closed at $243.98 on Wednesday. See how other analysts view this stock.
Goldman Sachs analyst Bruno Montanari downgraded Xometry Inc (NASDAQ:XMTR) from Buy to Neutral and raised the price target from $42 to $49. Xometry shares closed at $48.69 on Wednesday. See how other analysts view this stock.

Considering buying VRSK stock? Here’s what analysts think:

Read This Next:

Top 2 Financial Stocks That May Collapse This Quarter

Photo via Shutterstock

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.